Clinical Trial Update: Naltrexone for Bipolar Disorder and Alcohol Dependence [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating naltrexone for bipolar disorder and alcohol dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Bipolar Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Bipolar Disorder, Alcohol Dependence | Phase 4 | Status: COMPLETED